Efferon is a biotech company developing patented hemoadsorption technologies designed to remove endotoxins and inflammatory mediators
Efferon has raised $2.9M in total funding. The most recent round was Seed. The last funding was announced in May 2026.
Efferon is headquartered in Villach, Austria.
Efferon is a biotech company developing patented hemoadsorption technologies designed to remove endotoxins and inflammatory mediators
Efferon is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Efferon — Funding & Investors." VCBacked, May 21, 2026, https://www.vcbacked.co/company/efferon. Accessed August 7, 2026.
VCBacked. (2026). Efferon — Funding & Investors. Retrieved August 7, 2026, from https://www.vcbacked.co/company/efferon
{{cite web |title=Efferon — Funding & Investors |url=https://www.vcbacked.co/company/efferon |website=VCBacked |access-date=August 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated